Verastem, Inc. (0LOV.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
As of 03:49PM BST. Market open.
| Previous close | 1.0920 |
| Open | 1.1320 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 1.1307 - 1.1320 |
| 52-week range | 1.1307 - 1.1320 |
| Volume | |
| Avg. volume | N/A |
| Market cap | 868,952 |
| Beta (5Y monthly) | 0.77 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.4110 |
| Earnings date | 08 Aug 2022 - 13 Aug 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Is Verastem (NASDAQ:VSTM) Using Too Much Debt?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
- Business Wire
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, July 07, 2022--Verastem Oncology (Nasdaq:VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the grant of stock options to purchase 120,500 shares of its common stock and the grant of 80,400 restricted stock units (RSUs) to four new employees. The awards were granted pursuant to the Nasdaq inducement grant exception as an inducement material to the employees’ acceptance of employment with Verastem Oncology in accordance with N
- Simply Wall St.
What You Need To Know About Verastem, Inc.'s (NASDAQ:VSTM) Investor Composition
The big shareholder groups in Verastem, Inc. ( NASDAQ:VSTM ) have power over the company. Institutions often own shares...
© 2022 Yahoo. All rights reserved.
